India's Pharmaceutical Exports

Country Profile

Philippines

Philippines is a major destination for Indian pharmaceutical exports — $449M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 82% of shipments, with vaccines contributing $50.8M. The compound annual growth rate since FY2015 stands at 12.1%.

🇵🇭 #14 Destination · $449M · 3.5× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$449M
Exports FY2025–26 DGCIS
3.5×
Growth FY2015→2026
1.4%
Share of India Total
#14
Rank Among 178 Markets
12.1%
CAGR FY2015→2026
Philippines is a major destination for Indian pharmaceutical exports — $449M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 82% of shipments, with vaccines contributing $50.8M. The compound annual growth rate since FY2015 stands at 12.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $368M (82.1%) Vaccines $50.8M (11.3%) Medicine Ingredients $16.1M (3.6%) Surgical & Hospital Supplies $10.0M (2.2%) Traditional & Herbal $3.41M (0.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Philippines in the RBI overseas direct investment dataset (2011–2026).